Paper41269403
Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's Disease.
Jin J and 6 others. Mol Neurobiol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's Disease. Papers, record 41269403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41269403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's Disease.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, sigma | Major topic |
| Huntington Disease | Major topic |
| Neuroprotective Agents | Major topic |
| Piperidines | Major topic |
| Animals | |
| Sigma-1 Receptor | |
| Mice | |
| Humans | |
| Neurons | |
| Huntingtin Protein |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32995944 | Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study. | Eur J Nucl Med Mol Imaging | 2021 | https://conductscience.org/library/papers/32995944 | PubMed |
| 2 | 22251921 | Sigma-2 ligands induce tumour cell death by multiple signalling pathways. | Br J Cancer | 2012 | https://conductscience.org/library/papers/22251921 | PubMed |
| 3 | 37979148 | Synthesis and Biological Evaluation of Enantiomerically Pure (R)- and (S)-[18F]OF-NB1 for Imaging the GluN2B Subunit-Containing NMDA Receptors. | J Med Chem | 2023 | https://conductscience.org/library/papers/37979148 | PubMed |
| 4 | 22890883 | 2-Aminopyridine derivatives as potential σ(2) receptor antagonists. | ChemMedChem | 2012 | https://conductscience.org/library/papers/22890883 | PubMed |
| 5 | 27818324 | The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. | Neurobiol Dis | 2017 | https://conductscience.org/library/papers/27818324 | PubMed |
| 6 | 35941180 | Chromatin compaction precedes apoptosis in developing neurons. | Commun Biol | 2022 | https://conductscience.org/library/papers/35941180 | PubMed |
| 7 | 35507432 | Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine. | Autophagy | 2023 | https://conductscience.org/library/papers/35507432 | PubMed |
| 8 | 33797036 | The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models. | Neurotherapeutics | 2021 | https://conductscience.org/library/papers/33797036 | PubMed |
| 9 | 17981125 | Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. | Cell | 2007 | https://conductscience.org/library/papers/17981125 | PubMed |
| 10 | 17184842 | Simultaneous labeling of projecting neurons and apoptotic state. | J Neurosci Methods | 2007 | https://conductscience.org/library/papers/17184842 | PubMed |
| 11 | 24505464 | Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity. | PLoS One | 2014 | https://conductscience.org/library/papers/24505464 | PubMed |
| 12 | 37047224 | Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047224 | PubMed |
| 13 | 30575996 | Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques. | Mov Disord | 2019 | https://conductscience.org/library/papers/30575996 | PubMed |
| 14 | 34076441 | Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective. | J Med Chem | 2021 | https://conductscience.org/library/papers/34076441 | PubMed |
| 15 | 27466197 | Pridopidine activates neuroprotective pathways impaired in Huntington Disease. | Hum Mol Genet | 2016 | https://conductscience.org/library/papers/27466197 | PubMed |
| 16 | 28653853 | Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats. | J Proteome Res | 2017 | https://conductscience.org/library/papers/28653853 | PubMed |
| 17 | 30443021 | Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex. | Sci Rep | 2018 | https://conductscience.org/library/papers/30443021 | PubMed |
| 18 | 40430478 | A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer's Disease. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430478 | PubMed |
| 19 | 26159455 | Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses. | Psychopharmacology (Berl) | 2015 | https://conductscience.org/library/papers/26159455 | PubMed |
| 20 | 33871049 | Pridopidine reduces mutant huntingtin-induced endoplasmic reticulum stress by modulation of the Sigma-1 receptor. | J Neurochem | 2021 | https://conductscience.org/library/papers/33871049 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41471389 | Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471389 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41269403
GET https://conductscience.org/api/papers/v1/41269403/references?page=2